Raman spectroscopy for cancer diagnosis: how far have we come?

被引:18
|
作者
Culha, Mustafa [1 ]
机构
[1] Yeditepe Univ, Fac Engn & Architecture, Dept Genet & Bioengn, TR-34755 Istanbul, Turkey
关键词
LABEL-FREE DETECTION; INTEROBSERVER REPRODUCIBILITY; SCATTERING MICROSCOPY; OBJECTIVE DIAGNOSIS; PROSTATIC-CARCINOMA; BREAST-CANCER; ORAL-CANCER; TISSUE; TUMORS; IDENTIFICATION;
D O I
10.4155/bio.15.190
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Raman spectroscopy is increasingly investigated for cancer diagnosis. As the potential of the technique is explored and realized, it is slowly making its way into clinics. There are more reports in recent years showing promise that it can help clinicians for cancer diagnosis. However, a number of challenges remain to be overcome, especially in vivo cancer diagnosis. In this article, the recent progress of the technique toward clinical cancer diagnosis is discussed from a critical perspective.
引用
收藏
页码:2813 / 2824
页数:12
相关论文
共 50 条
  • [1] How far have we come in terms of estrogens in breast cancer?
    McNamara, Keely May
    Guestini, Fouzia
    Sakurai, Minako
    Kikuchi, Kyoko
    Sasano, Hironobu
    ENDOCRINE JOURNAL, 2016, 63 (05) : 413 - 424
  • [2] Early diagnostic protein biomarkers for breast cancer: how far have we come?
    Winden, Annemieke W. J. Opstal-van
    Vermeulen, Roel C. H.
    Peeters, Petra H. M.
    Beijnen, Jos H.
    van Gils, Carla H.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 1 - 12
  • [3] HIV Cure: How Far We Have Come?
    Maurya, Shesh Prakash
    Shrivastav, Abhishek
    Rawat, Vivek Singh
    Gautam, Hitender
    Das, Bimal Kumar
    INDIAN JOURNAL OF MICROBIOLOGY, 2024,
  • [4] Phytic acid: How far have we come?
    Ali, Muhammad
    Shuja, Malik Nawaz
    Zahoor, Muhammad
    Qadri, Ishtiaq
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2010, 9 (11): : 1551 - 1554
  • [5] DEFINING THE SYMPTOM CLUSTER: HOW FAR HAVE WE COME?
    Barsevick, Andrea
    SEMINARS IN ONCOLOGY NURSING, 2016, 32 (04) : 334 - 350
  • [6] Early diagnostic protein biomarkers for breast cancer: how far have we come?
    Annemieke W. J. Opstal-van Winden
    Roel C. H. Vermeulen
    Petra H. M. Peeters
    Jos H. Beijnen
    Carla H. van Gils
    Breast Cancer Research and Treatment, 2012, 134 : 1 - 12
  • [7] Systems human factors: how far have we come?
    Norris, Beverley J.
    BMJ QUALITY & SAFETY, 2012, 21 (09) : 713 - 714
  • [8] Look how far we have come: BREAST cancer detection education on the international stage
    Trieu, Phuong Dung
    Mello-Thoms, Claudia R.
    Barron, Melissa L.
    Lewis, Sarah J.
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [9] The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
    Metcalfe, Kelly A.
    Gronwald, Jacek
    Tung, Nadine M.
    McCuaig, Jeanna M.
    Eisen, Andrea
    Elser, Christine
    Foulkes, William D.
    Neuhausen, Susan L.
    Senter, Leigha
    Moller, Pal
    Bordeleau, Louise
    Fruscio, Robert
    Velsher, Lea
    Zakalik, Dana
    Olopade, Olufunmilayo, I
    Eng, Charis
    Pal, Tuya
    Cullinane, Carey A.
    Couch, Fergus J.
    Kotsopoulos, Joanne
    Sun, Ping
    Lubinski, Jan
    Narod, Steven A.
    CANCER, 2023, 129 (06) : 901 - 907
  • [10] Place attachment: How far have we come in the last 40 years?
    Lewicka, Maria
    JOURNAL OF ENVIRONMENTAL PSYCHOLOGY, 2011, 31 (03) : 207 - 230